`

Deverra Therapeutics

Biotechnology

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$3.5M
size-icon Size
11 - 50

Frequently Asked Questions About Deverra Therapeutics

What does Deverra therapeutics do?+

Deverra Therapeutics is a clinical stage biotechnology company dedicated to the development of allogeneic, off-the-shelf cellular immunotherapies for on-demand treatment of patients with cancer and infectious diseases. The company has an exclusive license to a proprietary stem cell expansion and directed-differentiation platform from the Fred Hutchinson Cancer Research Center based on more than 20 years of federally funded research and data from 5 clinical trials. This platform can be used to generate a range of unmodified and modified immune cells to treat patients with cancer and infectious diseases

What is Deverra therapeutics's industry? +

Deverra therapeutics operates in the Biotechnology industry.

What is Deverra therapeutics's revenue? +

Deverra therapeutics's revenue is 11m - 100m

What is Deverra therapeutics's company size? +

Deverra therapeutics has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.